Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.
The infectious agent of prion diseases is identified with PrP(Sc), a beta-rich, amyloidogenic and partially protease resistant isoform of the cellular glycoprotein, PrP(C). To understand the process of prion formation in vivo, we and others have studied defined misfolding pathways of recombinant PrP in vitro. The low-level infectivity of the in vitro misfolded murine PrP amyloid has recently been reported. Here we analyze the in vitro kinetics of amyloid formation from recombinant human PrP(90-231) in vitro in the context of two common allelic forms of PrP found in human populations that are associated with differences in prion disease susceptibility and pathological phenotype. We show that human PrP amyloid forms readily from its PrP(C)-like state in vitro, that the lag time of the reaction can be further shortened by the presence of a "seed" of pre-formed PrP amyloid, and that amyloid propagation is more complex than a simple crystallization process. We further show that the kinetics of amyloid formation do not differ between the Met129 and Val129 allelomorphs of human PrP, and that amyloid from each functions as an equally effective seed in heterologous, as in homologous amyloid reactions. The results could illuminate the process of amyloid formation in vivo as well as help understanding prion pathogenesis.
Tahiri-Alaoui
Abdessamad
A
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
James
William
W
D000682:Amyloid / Q000737:chemistry* / Q000648:ultrastructure; D006801:Humans; D007700:Kinetics; D011110:Polymorphism, Genetic; D011328:Prions / Q000737:chemistry* / Q000235:genetics; D017510:Protein Folding; D011994:Recombinant Proteins / Q000737:chemistry
D000682:Amyloid; D011328:Prions; D011994:Recombinant Proteins
Biochemistry. 1999 Mar 16;38(11):3258-67
10079068
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6010-4
9600908
Biochemistry. 1999 Oct 19;38(42):14101-8
10529258
Nat Cell Biol. 1999 May;1(1):55-9
10559865
J Biol Chem. 2001 Jun 8;276(23):19687-90
11306559
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3563-8
11891310
Biochemistry. 2002 Apr 9;41(14):4694-703
11926832
J Biol Chem. 2002 Jun 14;277(24):21140-8
11912192
J Biol Chem. 2002 Nov 22;277(47):44589-92
12356762
Protein Sci. 2003 Mar;12(3):600-8
12592030
J Biol Chem. 2003 Oct 10;278(41):39697-705
12902353
J Mol Biol. 2004 Jan 2;335(1):221-31
14659752
Protein Sci. 2004 Mar;13(3):586-95
14767078
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4335-6
15070716
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8342-7
15155909
J Biol Chem. 2004 Jul 2;279(27):28515-21
15123682
J Biol Chem. 2004 Jul 23;279(30):31390-7
15131108
Cell. 1983 Dec;35(2 Pt 1):349-58
6418385
Lancet. 1991 Jun 15;337(8755):1441-2
1675319
Science. 1991 Jun 14;252(5012):1515-22
1675487
Neurology. 1994 Feb;44(2):291-3
8309577
Trends Biochem Sci. 1996 Dec;21(12):482-7
9009832
Nat Struct Biol. 1999 Jun;6(6):550-3
10360358